Alongside testing the effects of plumbagin experimentally in various tumor cells, we also tested the hypothesis of plumbagin-mediated NF-κB inhibition as the key reason for the reduction in CXCR4 and other metastatic genes, in a virtual, predictive, tumor cell system. Here, NFKB1 is linked to neoplasm.